FDA vaccines chief hopes for common ground with RFK Jr.
The FDA's Dr. Peter Marks says he hopes to keep his job under a second Trump term, and urges Robert F. Kennedy Jr. to "keep ...
New FDA rules for TV drug ads: Simpler language and no distractions
Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...
RFK Jr.'s plan for changing the U.S. food and drug system
Robert F. Kennedy Jr., an environmental and anti-vaccine activist, was selected by President-elect Donald Trump to lead the ...
FDA's New Rules Require TV Drug Ads to Be Clearer, More Direct
The U.S. Food and Drug Administration ( FDA) now requires TV and radio drug ads to be clearer and more direct. The new ...
Recalled Cheeseburgers Given Highest Risk Level by FDA
Cheeseburgers recalled due to possible listeria could be life-threatening, according to risk classification by the FDA.
New FDA rules target those ubiquitous TV drug commercials
The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers ...
AOL18h
FDA employees consider quitting if RFK Jr. joins Trump's administration
The former officials are still in touch with colleagues who work at the FDA. Staff turnover is typical when a new ...
STAT14h
Facing a dialogue with RFK Jr., a top FDA official mounts a public defense of vaccines
Facing with a dialogue with RFK Jr., a top FDA official mounts a public defense of vaccines — and pleads for open minds.
federalnewsnetwork.com5h
FDA sees high vacancy rates for drug manufacturer inspectors
Learn how DLA, GSA’s Federal Acquisition Service and the State Department are modernizing their contract and acquisition ...
FiercePharma18h
GAO takes FDA to task over lagging plant inspections, recommends action plan
“FDA has not yet developed action plans to fully address travel, workload, and work-life balance because potential solutions ...
Targeted Oncology10h
FDA Approval Sought for Dato-DXd in EGFR-Mutated NSCLC
A new BLA for datopotamab deruxtecan aims for FDA accelerated approval to treat EGFR-mutated NSCLC based on data from ...